MiniMed™ Mobile

CareLink™ Connect

MyCareLink Heart™

Penny -All-In-One

CONTA SU DI ME MEDTRONIC

Guardian™

CareLink™ Clinical

Diabetes Updater

MyCareLink Smart™ EU

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

HSTS

Google Maps

Amazon

Content Delivery Network

LetsEncrypt

Mobile Non Scaleable Content

Chief Medical Officer

Alan Cheng

Vice President Finance and CFO of Renal Care Solutions

Alex Sexson

Senior Finance Director, CFO Respiratory Interventions

Allison Seeber

Operating Unit President, Medtronic ENT

Amy Van Sach

Senior Finance Director, Global Operations & Supply Chain / Global Supply Management

Andrew Tibesar

President Respiratory Interventions Operating Unit

Ariel Mactavish

Senior Director, Global Marketing & P&L Owner, Digital-Assisted Surgery (DAS), Surgical Robotics

Arvind Ramadorai

VP Finance | Diabetes CFO

Austin Domenici

Corporate Sector CFO

Becky Ciampone

EVP and President, Neuroscience Portfolio

Brett Wall

Shirley Ann Jackson

Randall Hogan

Denise O'Leary

Craig Arnold

Bob Pozen

Kendall Powell

Omar Ishrak

Greg Lewis

Rob Ten Hoedt

Senior Vice President & President, EMEA & Canada

Paul J. Robinson

Director of Operations

Marc Stein

Technical Fellow and Senior Member

Sean Lennon

Jeff Kramer

Vice President, Research and Technology, RTG

Todd Gillenwater

Senior Director, Government Affairs

Eileen Sheil

Vice President Communications

Amit Kapila Sharma

Data & AI Business Development (Cranial & Spinal Technologies)

Rockley Photonics manufactures photonics chips and custom integrated packaged products.

CathWorks is a medical technology company focused transforming how cardiovascular disease is diagnosed and treated.

Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.

Acufocus is a medical device company that develops and markets KAMRA inlay for the treatment of near vision loss.

AEGEA Medical manufactures surgical and medical instruments.

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

PowerVision is a device company developing implantable intraocular lenses.

Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery.

Titan Medical engages in the design and development of SPORT single-port robotic surgical system for minimally invasive surgery (MIS).

Midwestern US Investors

Artificial Intelligence (AI) Public Companies With More Than $1M in Revenue

United States Companies With More Than $50M in Revenue (Top 10K)

Investors Active in Portsmouth, New Hampshire

Medtronic provides healthcare technology solutions for complex and challenging conditions. They deliver treatments and therapies for the lungs, brain, dental, diabetes, ENT, heart, gastrointestinal, orthopedic, urinary, and women's health. The company's technologies and therapies treat 70 different medical conditions and include patient monitoring systems, robotic surgery, insulin pumps, cardiac devices, and more. Medtronic delivers innovative technologies that change people's lives through to its extensive knowledge, insatiable curiosity, and desire to assist everyone in need.

Post-IPO Debt - Medtronic

NHS England

Grant - Medtronic

Blackstone Life Sciences

Post-IPO Equity - Medtronic

Trade Capital Funding

Medtronic China Phase II Fund

Minneapolis

Minnesota

United States

North America

Medtronic

Medtronic’s Affera PFA snags FDA approval

Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments

Boston Sci, Medtronic fare well in NICE review of remote monitoring

Philips announces strategic advocacy partnership with Medtronic

Medtronic expands reach of its latest TAVR valve with European approval

Medtronic Gets FDA IDE Nod for Prevail Drug-Coated Balloon Study

Medtronic Executive's Telework Tests Minnesota's 'Employee' Rule

FDA OKs study of Medtronic’s Affera in ventricular tachycardia

Medtronic Wins FDA Nod for Affera with Sphere-9 Early Feasibility Study

Solventum Hires Surgeon Dr. Ryan Egeland as Chief Medical Officer

Spain

Europe

Italy

Germany

Japan

Asia

HTML5

Lightbox

Akamai Intelligent Platform

Google Doubleclick

Fonts.com

Adobe Fonts

Symantec Email Security.Cloud

Twilio

Oracle Eloqua

Apache Server

Medtronic owns Vitatron BV

Medtronic owns United States Surgical Corporation

Medtronic owns Synectics Medical

Medtronic owns Medtronic Vascular

Medtronic owns Medtronic’s Endovascular Innovations

Medtronic owns Medtronic Peripheral Therapies

Medtronic owns Medtronic Navigation

Medtronic owns Medtronic, Europe

Medtronic owns Magnolia Medical Technologies

Medtronic owns Covidien

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

news impact assignment basic	general	Nov 21, 2024 8:04 AM	96a39ccc
public peers	general
news daily refresh	general	Dec 4, 2024 2:16 PM	7d74071d
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 2:23 PM	3ac24b99
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:51 PM	febb8e90
crunchbase profile	general	Oct 28, 2024 1:58 PM	ccd0c5e7
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	e16e0536
peers	general
news basic	general	Dec 4, 2024 2:13 PM	862641d2
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:MEDTRONIC

Medtronic plc

Last Close

84.74

22/11 21:00

Market Cap

98.81B

Beta: -

Volume Today

5.40M

Avg: -